For research and educational purposes only. Not medical advice.
Dulaglutide Reference
Educational, not medical advice reference for Dulaglutide: GLP-1, Fat Loss; regulatory status, evidence posture, source review, and schedule notes. Also know…
Reference summary
Dulaglutide has a large approved-label evidence base in type 2 diabetes, including cardiovascular outcomes data. pepSmart surfaces label-reference schedules only.
- Categories
- GLP-1, Fat Loss
- Aliases
- Trulicity, LY2189265
- Evidence posture
- human
- Regulatory status
- FDA-approved dulaglutide label reference exists for Trulicity once-weekly subcutaneous use in adults with type 2 diabetes. It is not approved as a weight-loss medication.
- Content review status
- label verified